23.500
+0,00%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +52.1% | +42.7% | 2 / 3 | +23.4% | -0.16 pp | +1.49 pp | +24.6% | 0.23 | 5.11 | 471 | +23,4% | 37,1 | +52,1% | 5.11 | 7.25 | −29,5% |
| Pts | 8 | 8 | 8 | 12 | 4 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 23.500 (close price on 2026-10-19)EPS (TTM): 4.597
Financial charts
1.Revenue & growth
VND bn472Q2/26
1.Revenue & growth
VND bn472Q2/26
2.Profit & growth
VND bn37,1Q2/26
3.Profit mix (Penman)
VND bn158Q2/26
4.Margins & cost structure
%20.3%Q2/26
5.Returns & cash cycle
% · days23.4%Q2/26
6.Earnings quality & cash
VND bn182Q2/26
7.Asset structure
VND bn843Q2/26
8.Funding & debt health
VND bn · times843Q2/26
9.Revenue backlog
VND bn0,14Q2/26
10.Valuation
times · %5,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.352Q2/26
Adjusted EPS growth, latest quarter
52.1%
Average adjusted EPS growth, 3 quarters
42.7%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26